Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Carbohydrate or lignin – or derivative
Patent
1990-10-29
1992-02-04
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Carbohydrate or lignin, or derivative
514786, 514944, 514946, 514947, A61K 4700
Patent
active
050860771
ABSTRACT:
A novel endermic medicament having a consistency of a gel is proposed which is formulated, as a gel base, with non-ionic water-soluble cellulose ether, e.g., methyl cellulose and hydroxypropyl methyl cellulose, modified with a modification agent containing, in the molecule, an alkyl group having 6 to 26 carbon atoms and a functional group having reactivity with the hydroxyl group in the cellulose ether, e.g., stearyl glycidyl ether, decyl glycidyl ether and cetyl epoxide. The endermic medicament formulated with the modified cellulose ether is stable by virtue of the very little interaction between the active ingredients and the gel base and also can exhibit high percutaneous absorptivity of the active ingredients through the human skin.
REFERENCES:
patent: 4543258 (1985-09-01), Urata et al.
patent: 4832943 (1989-05-01), Grollier et al.
Technical Publication, Shin-Etsu Chemical Co., Ltd., Tokyo, "Metolose", pp. 1-17 (1977).
Chemical Abstracts 101:210861m (1984).
Chiba Tohru
Ikeda Kaori
Mizuno Sumiko
Muto Hiroaki
Obara Sakae
Schenkman Leonard
Shin-Etsu Chemical Co. , Ltd.
LandOfFree
Endermic medicament with a gel base does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endermic medicament with a gel base, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endermic medicament with a gel base will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-348273